Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€450.10

€450.10

-1.010%
-4.6
-1.010%
€540.08
 
22:26 / Tradegate WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Stock / Healthcare Providers & Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

UnitedHealth Group Inc. Stock

We can see a decrease in the price for UnitedHealth Group Inc.. Compared to yesterday it has lost -€4.600 (-1.010%).
With 41 Buy predictions and 1 Sell predictions UnitedHealth Group Inc. is one of the favorites of our community.
With a target price of 540 € there is a slightly positive potential of 19.97% for UnitedHealth Group Inc. compared to the current price of 450.1 €.
So far the community has only identified positive things for UnitedHealth Group Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of UnitedHealth Group Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of UnitedHealth Group Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
UnitedHealth Group Inc. -1.010% 0.187% -1.927% 3.652% -4.397% 32.005% 110.464%
Centene Corp. -0.840% -1.779% -4.080% 0.211% -7.440% -1.072% 36.959%
Humana Inc. 0.270% -0.531% 1.688% -17.567% -18.404% -11.374% 45.714%
Cigna Corp. -2.710% -4.684% -2.776% 17.270% 11.208% 50.050% 106.805%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-06

UnitedHealth Group Incorporated (NYSE: UNH) is a leading company in the healthcare providers and services industry, with impressive financials that initially suggest strength and growth potential. Over the years, UnitedHealth has shown a consistent increase in assets, revenues, and net income, while effectively managing its liabilities. However, as with any company, there are pros and cons to consider for a more comprehensive understanding of UnitedHealth's overall financial position.

Increasing total assets: From 2020 to 2022, UnitedHealth's total assets have increased from approximately $197 billion to $245 billion, demonstrating a growth trend in the company's resources.

Growing revenue and net income: The total revenue progressively grew from about $255 billion in 2020 to $322 billion in 2022. Similarly, the net income increased from approximately $15.4 billion in 2020 to $20.1 billion in 2022, indicating improving profitability.

Comments

Prediction Buy
Perf. (%) -4.91%
Target price 510.000
Change
Ends at 30.06.25

UnitedHealth Group Inc. is a healthcare giant that has weathered the pandemic storm quite well. The company's diversified business model, encompassing insurance, healthcare services, and pharmacy benefits management, has proven to be a resilient asset. Recent news suggests that UnitedHealth could be a beneficiary of a second Trump term, as the managed care industry is expected to fare well under continued Republican leadership. Additionally, the company's recent $20 million settlement with the Department of Justice over opioid prescription issues, while not ideal, demonstrates its ability to navigate regulatory challenges. With a strong market position, impressive financials, and a seemingly favorable political landscape, I believe UnitedHealth is well-positioned for continued growth. The stock's current price of $474.65 appears reasonable, and I would recommend a buy with a target price of $510.00, as the company's fundamentals and growth prospects appear promising.
Show more

Prediction Buy
Perf. (%) 0.05%
Target price 544.961
Change
Ends at 12.06.25

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
Ratings data for UNH provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -3.27%
Target price 532.730
Change
Ends at 05.06.25

UnitedHealth Group Incorporated (NYSE: UNH) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $580.00 price target on the stock.
Ratings data for UNH provided by MarketBeat
Show more

News

Is UnitedHealth Group Stock a Millionaire Maker?: https://g.foolcdn.com/editorial/images/780725/a-couple-smiling-and-talking-with-an-advisor.jpg
Is UnitedHealth Group Stock a Millionaire Maker?

Making a million dollars from a single stock sounds like it could be an unrealistic goal. But if you pick a good growth stock, which also pays a dividend, and hold on to it for the long haul, it's

Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?: https://g.foolcdn.com/editorial/images/780172/scientists-smiling-and-shaking-hands.jpg
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?

Johnson & Johnson reigned as the largest healthcare company in the world for years. UnitedHealth Group also took a turn at the top. However, the title now belongs to Eli Lilly (NYSE: LLY) -- and it

What Is the Dividend Payout for UnitedHealth Group Stock?: https://g.foolcdn.com/editorial/images/779798/unh-united-healthcare-stock-dividend-income-dividends.jpg
What Is the Dividend Payout for UnitedHealth Group Stock?

Healthcare giants sometimes pay decent dividend distributions, and UnitedHealth Group (NYSE: UNH) certainly falls into that category. In the wake of difficult circumstances, however, investors might